The affidavit said the informant called the FBI Wednesday to say he was a research scientist and had been contacted by Harris and Leavitt, who asked him to use some of his equipment to test vials of the bacterium Bacillus anthracis
, which causes anthrax.
A snapshot of the global therapeutic scenario for Bacillus Anthracis
a privately held biotechnology company dedicated to the development of biodefense products, announced today that the companies have entered into a collaboration agreement under which the companies plan to develop and commercialize MDX-1303, a fully human monoclonal antibody targeting the Bacillus anthracis
Army Dugway Proving Grounds in Utah, RAMP was demonstrated to reliably detect Bacillus anthracis
isolates representing a wide variety of geographic sources and physical variants.
This diagnosis was supported by seroconversion to protective antigen of Bacillus anthracis
and the presence of antibodies against lethal factor.
Under terms of the agreement, the Army will perform various tests and laboratory assays to determine if Antex's lead antibiotic and other proprietary compounds are potent against fighting anthrax infections and diseases caused by Bacillus anthracis
His enemy is Bacillus anthracis
, the germ responsible for anthrax.
Anthrax is caused by toxins produced after infection with Bacillus anthracis
We used this technology to identify the warfare agent Bacillus anthracis
by sequencing 4 single nucleotide polymorphisms (SNPs) in the rpoB gene as chromosomal markers for B.
D) into the disinfection of Bacillus anthracis
spores (anthrax) with ultraviolet (UVC) technology.
Much to their surprise, this compound turned out to be a key component of the deadly toxin made by the bacterium Bacillus anthracis
The Pathogen Genomics Division is a joint program between TGen and Arizona's major universities, which results in a unified approach to protecting America against dangerous pathogens, in particular Bacillus anthracis
Development of internal controls for PCR detection of Bacillus anthracis
Data from a new study conducted in the test tube (in vitro) showed that Bacillus anthracis
developed lower resistance to doxycycline and to clarithromycin, the active ingredient in Abbott's marketed product, Biaxin(R), than to the other antimicrobial agents in this study.
Martin Crumrine of USAMRIID, Donald Robertson of Brigham Young University in Provo, Utah, and their collaborators are studying Bacillus anthracis
, the bacterium that causes anthrax.